CA9 and nonpapillary renal cell carcinoma: Patients with von Hippel-Lindau syndrome may represent another population of interest for future studies, given their predisposition to develop multiple CAIX-expressing tumours, including ccRCC, haemangioblastomas, and neuroendocrine tumours, all driven by VHL inactivation [57].